These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 90464)

  • 1. Serum glycoproteins in head and neck squamous carcinoma: correlations with tumor extent, clinical tumor stage, and T-cell levels during chemotherapy.
    Wolf GT; Chretien PB; Elias EG; Makuch RW; Baskies AM; Spiegel HE; Weiss JF
    Am J Surg; 1979 Oct; 138(4):489-500. PubMed ID: 90464
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of cancer of the head and neck.
    Bertino JR; Mosher MB; DeConti RC
    Cancer; 1973 May; 31(5):1141-9. PubMed ID: 4122299
    [No Abstract]   [Full Text] [Related]  

  • 3. The chemotherapy of head and neck cancer.
    Carter SK
    Semin Oncol; 1977 Dec; 4(4):413-24. PubMed ID: 74095
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin.
    Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ
    Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.
    Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T
    Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Raafat J; Oster MW
    Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place of chemotherapy in the treatment of advanced squamous carcinoma of the head and neck and in other situations.
    Stephens FO
    Med J Aust; 1974 Oct; 2(16):587-92. PubMed ID: 4140460
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR
    Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in head and neck cancer.
    Hong WK; Bromer R
    N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588
    [No Abstract]   [Full Text] [Related]  

  • 11. Single agents known to be active in head and neck cancer.
    Monfardini S; Volonterio A; Marchini S
    Chemioterapia; 1985 Aug; 4(4):303-9. PubMed ID: 2414016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial experiences with a new treatment protocol in otorhinolaryngologic cancers].
    Lehnert M; Jakse R; Scherlacher A; Tschech G
    Acta Med Austriaca Suppl; 1979; 6():337-9. PubMed ID: 95541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of head and neck cancer.
    Wittes RE
    Otolaryngol Clin North Am; 1980; 13(3):515-20. PubMed ID: 7003480
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for advanced carcinoma of head and neck: an effective outpatient schedule of Cytoxan, Oncovin, methotrexate and bleomycin.
    Didolkar MS; Coleman JJ; Elias EG; Gray WC; Cosentino E
    Head Neck Surg; 1981; 4(2):92-7. PubMed ID: 6171546
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck].
    Bruntsch U; Hiller T; Wandt H; Wolff L; Theissing J; Gallmeier WM
    Dtsch Med Wochenschr; 1985 Dec; 110(49):1889-92. PubMed ID: 2415315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy.
    Weichselbaum RR; Clark JR; Miller D; Posner MR; Ervin TJ
    Cancer; 1985 May; 55(9 Suppl):2149-55. PubMed ID: 2579724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 19. T-lymphocytes and survival of head and neck squamous cell carcinoma.
    Mason JM; Kitchens GG; Eastham RJ; Jennings BR
    Arch Otolaryngol; 1977 Apr; 103(4):223-7. PubMed ID: 300622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved therapeutic index of methotrexate with "leucovorin rescue".
    Levitt M; Mosher MB; DeConti RC; Farber LR; Skeel RT; Marsh JC; Mitchell MS; Papac RJ; Thomas ED; Bertino JR
    Cancer Res; 1973 Jul; 33(7):1729-34. PubMed ID: 4541737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.